3) Diagnostic Assays
Abstract
Development and verification of rapid, sensitive, and specific tests for the identification of Biological Warfare Agents (BWA) and their expressed pathogens and toxins in clinical specimens from Warfighters for the diagnosis of exposure/infection. Discovery of host biomarkers generated in response to exposure to biological threat agents, whether known or emerging. This effort is transferring in FY19 to TM2 (Techbase Med Defense) Medical Diagnostics.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2020
- Source ID
- db2e8b52d70c8e087f8adb5bf1097c43